Weighing the Evidence: Immunomodulatory Combinations (IO/IO and IO/TKI) for the Treatment of Clear Cell Renal Cell Cancer

home / precision-medicine / weighing-the-evidence-immunomodulatory-combinations-io-io-and-io-tki-for-the-treatment-of-ccrcc

Matthew Campbell, MD, MS, and Rana McKay, MD, provide a comprehensive overview of current treatment strategies, analyze long-term data from pivotal clinical trials, and explore ongoing challenges in clear cell renal cell carcinoma.

2 KOLs are featured in this program.

EP. 1: Current treatment options for ccRCC based on patient and disease factors

Matthew T. Campbell, MD, MS;Rana R. McKay, MD
June 26th 2024

Matthew Campbell, MD, MS, and Rana McKay, MD, offer a concise review of existing treatment approaches for clear cell renal cell carcinoma across risk categories, along with considerations for sequencing therapies.

Watch

2 KOLs are featured in this program.

EP. 2: CheckMate-214: Long-term follow-up data

Matthew T. Campbell, MD, MS;Rana R. McKay, MD
June 26th 2024

The key opinion leaders explore extended follow-up results from the CheckMate-214 clinical trial.

Watch